← All trials
NCT07168980
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2025
- Primary completion
- Jun 30, 2030
- Completion date
- Jun 30, 2030
- First posted
- Sep 11, 2025
- Last posted
- Sep 11, 2025
- Enrollment
- 87
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Children's Cancer Group, ChinaLead sponsor
- Huazhong University of Science and TechnologyCollaborator
- Nanjing Medical UniversityCollaborator
- Shandong UniversityCollaborator
- Tianjin Medical UniversityCollaborator
- Sichuan UniversityCollaborator
- Jiao Tong UniversityOfficial
- Jiao Tong UniversityCollaborator
- Central South UniversityCollaborator
- Soochow UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.